Metabolic Pathway Prediction via Correlation Networks
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for identifying metabolic pathways in organisms rely heavily on complex, constraint-based approaches that require prior knowledge and do not account for dynamic interactions between biochemically distant pathways, often relying on gene ontology rather than experimental evidence, and neglect the influence of endogenous or exogenous cues.
Innovation Solution
A system and method using correlation-based network analysis and machine learning to predict metabolic pathways from metabolite concentration correlation networks, mapping existing pathways onto metabolite correlation networks and computing network properties to derive a machine learning model that identifies previously unidentified pathways.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If constraint-based bottom-up approach with manual curation is used to identify metabolic pathways, then pathway identification accuracy is improved, but process complexity and time consumption increase significantly
Solution Approach 1:
The patent replaces the manual, constraint-based mechanical curation process with a computational machine learning system. The ML model automatically identifies metabolic pathways by analyzing metabolite concentration data and gene expression patterns, substituting human expert manual work with an automated algorithmic approach that maintains accuracy while reducing complexity and time requirements.
Solution Approach 2:
The patent creates a computational model that copies and simulates the complex manual curation process. By training the machine learning system on existing curated pathway data, it learns to replicate expert judgment and pathway identification capabilities without requiring actual manual curation for each new pathway discovery task.
2Reliability
If constraint-based approach with a priori knowledge is used, then pathway reconstruction reliability is improved, but adaptability to new conditions and dynamic interactions decreases
Solution Approach 1:
The patent introduces dynamic analysis by examining metabolite concentration changes over time and under different conditions. The machine learning model captures temporal patterns and condition-specific responses, allowing the system to adapt to dynamic metabolic interactions rather than relying solely on static, pre-defined pathway constraints.
Solution Approach 2:
The patent changes the fundamental parameters used for pathway identification from fixed constraint-based rules to flexible, data-driven parameters. By using metabolite concentration ratios, correlation coefficients, and expression pattern variations as dynamic parameters, the system can adapt to new conditions and discover pathways that may not fit traditional constraint definitions.
3Ease of operation
If gene ontology-based prediction is used for metabolic pathways, then ease of operation is improved, but measurement precision and experimental evidence requirement worsen
Solution Approach 1:
The patent merges multiple data sources including metabolite concentration measurements, gene expression data, and existing pathway knowledge into a unified machine learning analysis. This combination maintains ease of operation by automating the process while improving measurement precision through multi-omics integration and experimental validation, overcoming the limitations of gene ontology-based prediction alone.
4Loss of information
If traditional metabolite correlation network analysis is used, then holistic view of metabolite relationships is achieved, but ability to identify specific metabolic pathways and regulating enzymes decreases
Solution Approach 1:
The patent segments the holistic metabolite correlation network into specific functional pathways by using machine learning to identify pattern clusters corresponding to known pathway structures. The system divides the complex network into manageable pathway segments while preserving the overall relational context, enabling both holistic viewing and specific pathway detection simultaneously.
Solution Approach 2:
The patent adds a new dimension of analysis by integrating gene expression data with metabolite correlation networks. This multi-dimensional approach transforms the two-dimensional metabolite relationship map into a three-dimensional analysis space that includes regulatory information, enabling specific pathway and enzyme identification while maintaining the holistic metabolite relationship context.
Data Source
AI summary
A method and a system are provided for determining a likelihood of a metabolic pathway existing in an organism, including: calculating a feature vector for each metabolic pathway of metabolic pathways known to exist and not known to exist in the organism, wherein elements of the feature vectors are network properties of the metabolic pathways mapped to a metabolite concentration correlation network (CN); training a supervised machine learning model for classifying metabolic pathways as existing or not existing in the organism, according to the known and unknown feature vectors; determining, based on mapping to the CN, a feature vector of a proposed metabolic pathway, and feeding the feature vector of the proposed metabolic pathway to the trained SML model, to determine a likelihood of the proposed metabolic pathway existing in the organism.